Trademark search for:

KRENAVA

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2015-10-21 — Application filed
2016-01-21 — Sn assigned for sect 66a subseq desig from ib
2016-01-22 — Application filed
2016-01-28 — Application filed
2016-02-02 — Application filed
2016-02-05 — Assigned to examiner
2016-02-05 — Approved for pub - principal register
2016-03-02 — Notice of publication
2016-03-22 — Published for opposition
2016-06-07 — Registered-principal register
2016-07-07 — Grant of protection created, to be sent to ib
2016-07-08 — Final disposition recorded
2016-07-08 — Final disposition recorded
2016-12-09 — Notification processed by ib
2017-01-26 — International registration renewed
2022-12-23 — Cancelled section 71
2022-12-23 — Final status recorded
2023-08-23 — Total invalidation of reg ext protection created
2025-03-21 — Generic madrid transaction sent to ib
2025-03-21 — Invalidation reviewed - no action required by office
2025-03-21 — Generic madrid transaction created
2025-05-03 — Further decision processed by ib

Owner Information

Novartis AG
CH

Correspondent

Novartis Pharma AG, Trademark Department
Postfach
CH-4002 Basel,
SWITZERLAND

Filing Details

Filing Date:
2015-10-21

Status Date:
2022-12-23

Category:
Pharmaceuticals

Filing Year:
2007

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.